share_log

Cantor Fitzgerald Reiterates Overweight on Agios Pharmaceuticals

Moomoo 24/7 ·  Apr 9 08:27

Cantor Fitzgerald analyst Eric Schmidt reiterates Agios Pharmaceuticals (NASDAQ:AGIO) with a Overweight.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment